2018
DOI: 10.1111/bjh.15112
|View full text |Cite
|
Sign up to set email alerts
|

BSH Guideline: management of thrombotic and haemostatic issues in paediatric malignancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(25 citation statements)
references
References 117 publications
0
24
1
Order By: Relevance
“…Increasing research evidence shows that hypercoagulable state, malnutrition, and systemic inflammatory response affect tumorigenesis, tumor progression, and metastasis ( 9 , 36 ). The prognostic value of preoperative FARI is closely linked to patients with malignant tumors ( 23 , 29 31 ).…”
Section: Discussionmentioning
confidence: 99%
“…Increasing research evidence shows that hypercoagulable state, malnutrition, and systemic inflammatory response affect tumorigenesis, tumor progression, and metastasis ( 9 , 36 ). The prognostic value of preoperative FARI is closely linked to patients with malignant tumors ( 23 , 29 31 ).…”
Section: Discussionmentioning
confidence: 99%
“…Only limited evidence exists supporting the use of ATIII concentrates in either primary prevention or management following a VTE event (Hunault-Berger 2008). Further, direct oral anticoagulants (DOACs) (dabigatran, rivaroxaban, apixaban, and edoxaban) are potentially a better alternative to LMWH, as they act independently of ATIII and can be administered orally (Sibson 2018), albeit the bleeding risk needs to be balanced against the limited number of approved specific antidotes for DOACs. Consensus suggests that full dose thromboprophylaxis should be administered and is without excessive bleeding risk, when the platelet count is > 50 x 10 9 /L (Watson 2015).…”
Section: Description Of the Interventionmentioning
confidence: 99%
“…Coagulation should always be checked at diagnosis,12 although the correlation between serious haemorrhage, coagulopathy or the use of prophylactic plasma is questionable 13. When considering correction of abnormal clotting results in the absence of bleeding, it is important to consider the potential risks of administering plasma components.…”
Section: Complications and Managementmentioning
confidence: 99%